Evidence map›Paper›PMID 35209740›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Extremely low frequency electromagnetic stimulation reduces ischemic stroke volume by improving cerebral collateral blood flow.

Hannelore Kemps, Chantal Dessy, Laurent Dumas, Pierre Sonveaux, Lotte Alders, Jana Van Broeckhoven, Lena Perez Font, Sara Lambrichts, Sébastien Foulquier, Sven Hendrix and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Hannelore KempsBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.
Chantal DessyPole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Laurent DumasPole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Pierre SonveauxPole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Lotte AldersBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.
Jana Van BroeckhovenBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.
Lena Perez FontCentro Nacional de Electromagnetismo Aplicado (CNEA), Universidad de Oriente, Santiago de Cuba, Cuba.
Sara LambrichtsDepartment of Pharmacology and Toxicology, School for Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht, The Netherlands.
Sébastien FoulquierDepartment of Pharmacology and Toxicology, School for Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht, The Netherlands.
Sven HendrixBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.
Bert BrôneBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.ORCID 0000-0002-4851-9480
Robin LemmensKU Leuven, - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium.
Annelies BronckaersBiomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.
Hasselt University · BEUCLouvain · BEMaastricht University · NLMSH Medical School Hamburg – University of Applied Sciences and Medical University · DEUniversidad de Oriente · CUVIB-KU Leuven Center for Brain & Disease Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extremely low frequency electromagnetic stimulation (ELF-EMS) has been considered as a neuroprotective therapy for ischemic stroke based on its capacity to induce nitric oxide (NO) signaling. Here, we examined whether ELF-EMS reduces ischemic stroke volume by stimulating cerebral collateral perfusion. Moreover, the pathway responsible for ELF-EMS-induced NO production was investigated. ELF-EMS diminished infarct growth following experimental stroke in collateral-rich C57BL/6 mice, but not in collateral-scarce BALB/c mice, suggesting that decreased lesion sizes after ELF-EMS results from improved collateral blood flow.

Indexed as

Brain IschemiaIschemic StrokeAnimalsCerebrovascular CirculationCollateral CirculationElectromagnetic PhenomenaIschemiaMiceMice, Inbred BALB CMice, Inbred C57BLNitric OxideProto-Oncogene Proteins c-aktNitric OxideProto-Oncogene Proteins c-aktAkt-/eNOS pathwaycerebral collateral blood flowextremely low frequency electromagnetic stimulationischemic strokenitric oxide

Identifiers

PMID35209740
PMCPMC9125494
OpenAlexW4214536999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.